Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial
Multiples Valuation: Tong Ren Tang Technologies Co. Ltd.

Tong Ren Tang Technologies Co. Ltd. (1666.HK)

Industry: Drug Manufacturers - General Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $14.55 — $22.01
Selected (Average) $18.72
Upside to Live 322.55%
Full Range Fair Value
Range (Low - High) $15.59 — $26.07
Selected (Average) $22.01
Upside to Live 396.89%
Live Price $4.43

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
HZNP 26 Horizon Therapeuti 4,279 53.71 53.71 24.65 15.36 41.34 46.01
VIRP.PA 27 Virbac S.A. 3,255 9.78 7.78 5.68 4.92 5.43 5.68
4528.T 28 Ono Pharmaceutical 3,236 16.50 17.59 8.23 8.46 6.28 14.37
4151.T 29 Kyowa Kirin Co., L 3,169 33.60 34.95 11.82 11.09 11.27 11.73
CIPLA.BO 30 Cipla Limited 3,124 22.32 17.97 15.77 13.52 18.95 17.27
002422.SZ 31 Sichuan Kelun Phar 2,597 35.24 27.97 18.75 17.98 91.85 20.34
KLBF.JK 32 PT Kalbe Farma Tbk 2,053 14.66 13.84 9.29 8.69 14.72 10.39
1666.HK 33 Tong Ren Tang Tech 1,962 5.32 5.18 1.41 1.30 1.49 1.57
DPH.L 34 Dechra Pharmaceuti 1,930 137.84 137.25 29.30 25.25 - 33.03
ORNAV.HE 35 Orion Oyj 1,912 29.27 27.74 21.82 21.06 19.39 22.23
4536.T 36 Santen Pharmaceuti 1,872 17.22 16.35 8.30 7.96 12.41 11.39
2186.HK 37 Luye Pharma Group 1,772 10.52 10.53 4.66 3.90 6.83 6.18
600436.SS 38 Zhangzhou Pientzeh 1,388 49.07 45.14 45.75 42.78 60.34 43.15
003090.KS 39 Daewoong Co., Ltd. 1,375 11.52 10.29 2.20 1.56 4.42 3.74
301015.SZ 40 Qingdao Baheal Med 1,075 27.93 27.93 18.77 18.77 11.39 23.66
PNVL3.SA 41 Dimed S.A. Distrib 959 12.92 11.24 5.78 4.89 10.72 10.20

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple17.2217.599.298.6911.3311.73
Full Range Median Multiple22.3217.9711.8211.0911.9014.37
Industry Multiple32.1430.6915.3813.7522.5218.62
Market Implied Multiple5.245.101.371.271.451.53
Company (1666.HK) Multiple5.325.181.411.301.491.57
(*) Net Income / EBITDA / Revenue154158342371323306
Winsorized Enterprise ValueN/AN/A3,1743,2213,6653,593
Full Range Median Enterprise ValueN/AN/A4,0414,1093,8494,404
(-) Net Debt-336-336-336-336-336-336
Winsorized Equity Value2,6462,7753,5103,5574,0013,929
Full Range Median Equity Value3,4292,8354,3764,4454,1844,740
(/) Shares Outstanding182182182182182182
Winsorized Fair Value$14.55$15.27$19.31$19.57$22.01$21.61
Full Range Median Fair Value$18.86$15.59$24.07$24.45$23.02$26.07
Current Price$4.43$4.43$4.43$4.43$4.43$4.43
Upside / Downside228.55%244.59%335.85%341.66%396.80%387.87%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$10.19$10.69$13.52$13.70$15.41$15.13
Buy / Don't BuyBUYBUYBUYBUYBUYBUY